Indaptus Therapeutics Inc expected to post a loss of 58 cents a share - Earnings Preview

Indaptus Therapeutics

02/08/2023 13:02

* Indaptus Therapeutics Inc  INDP.OQ   INDP.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 4 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Indaptus
Therapeutics Inc
is for a loss of 58 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Indaptus
Therapeutics Inc is $8​, above​ its last closing price of $2.10.
​​​

This summary was machine generated August 2 at 12:02 GMT.  All
figures in US dollars  unless otherwise stated